UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 201

Sortiert nach

Molecular basis of Natural Killer cell dysfunction in Hepatocellular Carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S636-S636

2017

Volltextzugriff (PDF)

Drivers of protistan community autotrophy and heterotrophy in chemically stratified Antarctic lakes

Aquatic microbial ecology : international journal, 2019-01, Vol.82 (3), p.225-239

2019

Volltextzugriff (PDF)

Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence

Journal of hepatology, 2017, Vol.66 (1), p.S78-S78

2017

Volltextzugriff (PDF)

Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis

The pharmacogenomics journal, 2016-02, Vol.16 (1), p.18-29

2016

Volltextzugriff (PDF)

P0459 : Natural killer cell phenotypic profile in hepatocellular carcinoma (HCC) is predictive of clinical outcome after curative treatment

Journal of hepatology, 2015-04, Vol.62, p.S484-S484

2015

Volltextzugriff (PDF)

322 KIR AND HLA LOCI AS PREDICTORS OF HCC OUTCOME IN PATIENTS WITH HCV INFECTION

Journal of hepatology, 2013-04, Vol.58, p.S134-S135

2013

Volltextzugriff (PDF)

697 KIR2DL5 AND HLA-BW4I80 ARE ASSOCIATED WITH LONGER OVERALL SURVIVAL IN PATIENTS UNDERGOING LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2012-04, Vol.56, p.S276-S276

2012

Volltextzugriff (PDF)

OC-30 Interleukin-28B (IL-28B) polymorphism has no impact on the long-term outcome of patients with HCV-related cirrhosis: a 15-years retrospective-prospective cohort study

Digestive and liver disease, 2012-02, Vol.44, p.S10-S11

2012

Volltextzugriff (PDF)

F-49 Overall survival of patients undergoing liver resection for hepatocellular carcinoma may be predicted by KIR2DL5 and HLA Bw4I80 genotyping

Digestive and liver disease, 2012-02, Vol.44, p.S47-S47

2012

Volltextzugriff (PDF)

882 TUMOR LYMPHOCYTIC INFILTRATE: A PREDICTOR OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC

Journal of hepatology, 2010, Vol.52, p.S344-S344

2010

Volltextzugriff (PDF)

Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?

Digestive and liver disease, 2004-11, Vol.36 (11), p.703-711

2004

Volltextzugriff (PDF)

T.N.27 TUMOR INFILTRATING CD4 T CELLS AND LIVER INFILTRATING PROINFLAMMATORY T-CELLS AS PREDICTORS OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC

Digestive and liver disease, 2010, Vol.42, p.S24-S24

2010

Volltextzugriff (PDF)

Metabolic and functional recovery of tumor infiltrating NK-cells in Hepatocellular Carcinoma

Digestive and liver disease, 2020-02, Vol.52, p.e12-e12

2020

Volltextzugriff (PDF)

PS-142 - Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence

Journal of hepatology, 2017, Vol.66 (1), p.S78-S78

2017

Volltextzugriff (PDF)

Quantitative analysis of hepatitis B virus DNA by real-time amplification

European journal of clinical microbiology & infectious diseases, 2002, Vol.21 (1), p.22-26

2002

Volltextzugriff (PDF)

SAT-117 - Molecular basis of Natural Killer cell dysfunction in Hepatocellular Carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S636-S636

2017

Volltextzugriff (PDF)

Low levels of circulating invariant NKT cells predict hepatocellular carcinoma recurrence after curative resection

Digestive and liver disease, 2009, Vol.41 (5), p.A17-A17

2009

Volltextzugriff (PDF)

Natural killer cell trafficking dysfunction in hepatocellular carcinoma

Digestive and liver disease, 2018-02, Vol.50 (1), p.34-34

2018

Volltextzugriff (PDF)

The Impairment of CD8 Responses Limits the Selection of Escape Mutations in Acute Hepatitis C Virus Infection

Journal of Immunology, 2005-12, Vol.175 (11), p.7519-7529

2005

Volltextzugriff (PDF)

Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates

Journal of Clinical Microbiology, 1995-02, Vol.33 (2), p.265-269

1995

Volltextzugriff (PDF)

Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia

Haematologica (Roma), 2001-03, Vol.86 (3), p.318

2001

Volltextzugriff (PDF)

A real-time PCR method for the quantitative analysis of HBV DNA in serum and liver tissue

Journal of hepatology, 2001-04, Vol.34, p.141

Cariani, E

2001

Volltextzugriff (PDF)

Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay

Journal of Clinical Microbiology, 1994-09, Vol.32 (9), p.2280-2284

1994

Volltextzugriff (PDF)

Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis

Journal of hepatology, 1990, Vol.11 (2), p.226-231

1990

Volltextzugriff (PDF)

Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response

Annals of hematology, 2003-06, Vol.82 (6), p.333-335

2003

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular basis of Natural Killer cell dysfunction in Hepatocellular Carcinoma

Drivers of protistan community autotrophy and heterotrophy in chemically stratified Antarctic lakes

Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence

Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis

P0459 : Natural killer cell phenotypic profile in hepatocellular carcinoma (HCC) is predictive of clinical outcome after curative treatment

322 KIR AND HLA LOCI AS PREDICTORS OF HCC OUTCOME IN PATIENTS WITH HCV INFECTION

697 KIR2DL5 AND HLA-BW4I80 ARE ASSOCIATED WITH LONGER OVERALL SURVIVAL IN PATIENTS UNDERGOING LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA

OC-30 Interleukin-28B (IL-28B) polymorphism has no impact on the long-term outcome of patients with HCV-related cirrhosis: a 15-years retrospective-prospective cohort study

F-49 Overall survival of patients undergoing liver resection for hepatocellular carcinoma may be predicted by KIR2DL5 and HLA Bw4I80 genotyping

882 TUMOR LYMPHOCYTIC INFILTRATE: A PREDICTOR OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC

Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?

T.N.27 TUMOR INFILTRATING CD4 T CELLS AND LIVER INFILTRATING PROINFLAMMATORY T-CELLS AS PREDICTORS OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC

Metabolic and functional recovery of tumor infiltrating NK-cells in Hepatocellular Carcinoma

PS-142 - Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence

Quantitative analysis of hepatitis B virus DNA by real-time amplification

SAT-117 - Molecular basis of Natural Killer cell dysfunction in Hepatocellular Carcinoma

Low levels of circulating invariant NKT cells predict hepatocellular carcinoma recurrence after curative resection

Natural killer cell trafficking dysfunction in hepatocellular carcinoma

The Impairment of CD8 Responses Limits the Selection of Escape Mutations in Acute Hepatitis C Virus Infection

Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates

Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia

A real-time PCR method for the quantitative analysis of HBV DNA in serum and liver tissue

Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay

Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis

Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response

Suchergebnisse filtern